Outcomes with erlotinib (Tarceva®) in a Yorkshire cancer centre

被引：0
|
作者：
O'Toole, L. [1 ]
Bond, M. [1 ]
Snee, M. [1 ]
机构：
[1] Cookridge Hosp, Leeds LS16 6QB, W Yorkshire, England
来源：
LUNG CANCER | 2007年 / 57卷
关键词：
D O I：
10.1016/S0169-5002(07)70350-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
24
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [41] Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: The Tarceva Lung Cancer Investigation Trial
    Gatzemeier, Ulrich
    Pluzanska, Anna
    Szczesna, Aleksandra
    Kaukel, Eckhard
    Roubec, Jaromir
    De Rosa, Flavio
    Milanowski, Janusz
    Karnicka-Mlodkowski, Hanna
    Pesek, Milos
    Serwatowski, Piotr
    Ramlau, Rodryg
    Janaskova, Terezie
    Vansteenkiste, Johan
    Strausz, Janos
    Manikhas, Georgy Moiseevich
    Von Pawel, Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) : 1545 - 1552
  • [42] Teachers & training - Yorkshire Dance Centre
    不详
    DANCING TIMES, 2000, 90 (1073): : 459 - 459
  • [43] Breast cancer outcomes in South Asian population of West Yorkshire
    G Velikova
    L Booth
    C Johnston
    D Forman
    P Selby
    British Journal of Cancer, 2004, 90 : 1926 - 1932
  • [44] Breast cancer outcomes in South Asian population of West Yorkshire
    Velikova, G
    Booth, L
    Johnston, C
    Forman, D
    Selby, P
    BRITISH JOURNAL OF CANCER, 2004, 90 (10) : 1926 - 1932
  • [45] A phase II study of neoadjuvant erlotinib (tarceva) in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary results
    Pearson, Matthew
    Nix, Jeffrey
    Kim, William
    Grigson, Gayle
    Wallen, Eric
    Pruthi, Raj S.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 119 - 119
  • [46] Acute Generalized Exanthematous Pustulosis Induced by Erlotinib (Tarceva) with Superimposed Staphylococcus aureus Skin Infection in a Pancreatic Cancer Patient: A Case Report
    Liquete, Egbert
    Ali, Syed
    Kammo, Revark
    Ali, Moiz
    Alali, Fadi
    Challa, Hima
    Fata, Farid
    CASE REPORTS IN ONCOLOGY, 2012, 5 (02): : 253 - 259
  • [47] Epidermal growth factor receptor (EGFR) blockade with Tarceva™ (Erlotinib) potentiates the antitumor effect of ionizing radiation in bladder cancer cell lines
    Colquhoun, AJ
    Mellon, JK
    JOURNAL OF UROLOGY, 2004, 171 (04): : 252 - 252
  • [48] A phase I/Il Study of erlotinib (Tarceva) in combination with cisplatin in patients with recurrent or metastatic squamous cell cancer of the head and neck (HNSCC).
    Siu, LL
    Chen, X
    Tsao, M
    Dancey, J
    Pond, GR
    Klein, M
    Winquist, E
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6091S - 6091S
  • [49] Antitumor activity of the EGFR/TK inhibitor Tarceva™ (erlotinib, OSI-774) in tumor models
    Desai, B
    Higgins, B
    Smith, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S63 - S64
  • [50] Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma
    de Groot, J. F.
    Gilbert, M. R.
    Aldape, K.
    Hess, K. R.
    Hanna, T. A.
    Ictech, S.
    Groves, M. D.
    Conrad, C.
    Colman, H.
    Puduvalli, V. K.
    Levin, V.
    Yung, W. K. A.
    JOURNAL OF NEURO-ONCOLOGY, 2008, 90 (01) : 89 - 97
12345